Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2016

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:



	Three Months Ended September 30,						Nine Months Ended September 30,
(in millions)	2016			2015			2016			2015

Net sales
Interventional Cardiology	$	620		$	551		$	1,870		$	1,659
Peripheral Interventions	273			246			815			723
Cardiovascular	893			797			2,685			2,382

Cardiac Rhythm Management	498			483			1,481			1,456
Electrophysiology	64			61			192			182
Rhythm Management	562			544			1,673			1,638

Endoscopy	393			362			1,148			1,042
Urology and Pelvic Health	260			207			773			479
Neuromodulation	143			128			407			369
MedSurg	796			697			2,328			1,890
Net sales allocated to reportable segments	2,251			2,038			6,686			5,910
Impact of foreign currency fluctuations	(146		)	(150		)	(491		)	(411		)
	$	2,105		$	1,888		$	6,195		$	5,499

Income (loss) before income taxes
Cardiovascular	$	292		$	249		$	885		$	732
Rhythm Management	113			97			300			252
MedSurg	262			235			763			590
Operating income allocated to reportable segments	667			581			1,948			1,574
Corporate expenses and currency exchange	(156		)	(145		)	(446		)	(334		)
Intangible asset impairment charges; acquisition-related net charges and credits; restructuring- and restructuring-related net charges; litigation-related net charges and credits; and pension termination charges	(27		)	(604		)	(787		)	(935		)
Amortization expense	(136		)	(131		)	(408		)	(361		)
Operating income (loss)	348			(299		)	307			(56		)
Other expense, net	(91		)	(68		)	(219		)	(256		)
Income (loss) before income taxes	$	257		$	(367	)	$	88		$	(312	)